HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5-(4-phenylbutoxy)psoralen

structure in first source

Also Known As:

psora-4

Networked: 9 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        Furocoumarins: 490
        Ficusin: 1099
        5-(4-phenylbutoxy)psoralen: 9
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        Furocoumarins: 490
        Ficusin: 1099
        5-(4-phenylbutoxy)psoralen: 9
  - 3-Ring Heterocyclic Compounds
    - Furocoumarins: 490
      - Ficusin: 1099
        5-(4-phenylbutoxy)psoralen: 9

Experts

1.	Gulbins, Erich: 2 articles (01/2017 - 07/2012)
2.	Leanza, Luigi: 2 articles (01/2017 - 07/2012)
3.	Szabò, Ildikò: 2 articles (01/2017 - 07/2012)
4.	Zoratti, Mario: 2 articles (01/2017 - 07/2012)
5.	Chandy, K George: 2 articles (07/2012 - 06/2004)
6.	Abrardo, Chiara: 1 article (02/2021)
7.	Arcangeli, Annarosa: 1 article (02/2021)
8.	Becchetti, Andrea: 1 article (02/2021)
9.	Bertoni, Francesco: 1 article (02/2021)
10.	D'Amico, Massimo: 1 article (02/2021)

Related Diseases

1.	Glomerulonephritis 12/01/2010 - "These results suggest that T(EM) and some macrophages expressing Kv1.3 channels play a critical role in the pathogenesis of crescentic GN and that Psora-4 will be useful for the treatment of rapidly progressive glomerulonephritis."
2.	Phototoxic Dermatitis (Phototoxicity) 03/01/2005 - "It was found that 5-(3-phenylpropoxy)psoralen and 5-(4-phenylbutoxy)psoralen are similar or less phototoxic in vitro as 5-methoxypsoralen which is the furocoumarin with the weakest phototoxicity in vivo compared to psoralen, 8-methoxypsoralen and 4,5',8-trimethylpsoralen."
3.	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/01/2013 - "Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia."
4.	Proteinuria 12/01/2010 - "Rats given Psora-4 showed less proteinuria and fewer crescentic glomeruli than rats given the vehicle. "
5.	Optic Neuritis (Retrobulbar Neuritis) 07/01/2008 - "Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles."

Related Drugs and Biologics

1.	Clofazimine (Lamprene)
2.	Kv1.3 Potassium Channel
3.	Riluzole
4.	Trioxsalen (Trioxysalen)
5.	Furocoumarins (Furanocoumarins)
6.	Potassium
7.	Methoxsalen (Oxsoralen)
8.	Immunologic Factors (Immunomodulators)
9.	Ficusin (Psoralen)
10.	Autoantigens

Related Therapies and Procedures

1.	Therapeutics
2.	Subcutaneous Injections